LXRX- Lexicon Pharmaceuticals, Inc.

Name: Lexicon Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Lexicon Pharmaceuticals, Inc. (LXRX) has 9 insiders with recent SEC Form 4 filings, including 26 buys and 1 sell. LXRX is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Dir	Debbane Raymond	1.91M	$3.86M	-
CEO	Exton Michael	1.01M	$2.04M	-
CFO	Coiante Scott M	160.2K	$324.5K	-
VP	Granowitz Craig B	156.0K	$316.0K	-
VP	McDermott Wendy	149.3K	$302.4K	-

Activity

Buys and sells only

Transactions

10 filings · page 4

Date	Insider	Role	Type	Shares	Price	Value	Chg%
Aug 19, 2019	Coats Lonnel	President And CEO	Buy	40,000	$1.35	$54,028.72	+4.9%
Aug 2, 2019	Tessmer James F	VP, Finance &Accounting	Buy	10,000	$1.14	$11,400.00	+30.0%
Aug 2, 2019	Barker Sam L	Director	Buy	24,000	$1.18	$28,200.00	+35.1%
Jun 28, 2018	Invus Public Equities, L.P.78	Director, 10% Owner	Buy	182,838	$12.51	$2,287,376.72	+2.7%
Jun 25, 2018	Invus Public Equities, L.P.78	Director, 10% Owner	Buy	253,725	$12.99	$3,295,173.13	+4.1%
Jun 21, 2018	Invus Public Equities, L.P.78	Director, 10% Owner	Buy	72,973	$13.29	$970,045.19	+0.8%
Jun 18, 2018	Invus Public Equities, L.P.78	Director, 10% Owner	Buy	45,784	$12.98	$594,398.91	+0.8%
Jun 12, 2018	Invus Public Equities, L.P.78	Director, 10% Owner	Buy	235,396	$12.80	$3,014,123.06	+2.8%
Jun 8, 2018	Tessmer James F	VP, Finance &Accounting	Sale+OE	10,000	$12.91	$129,076.00	-28.1%
Jun 7, 2018	Invus Public Equities, L.P.78	Director, 10% Owner	Buy	325,639	$12.58	$4,095,065.19	+4.3%

← PrevPage 4Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC